These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8407753

  • 1. Side effects of methylphenidate and desipramine alone and in combination in children.
    Pataki CS, Carlson GA, Kelly KL, Rapport MD, Biancaniello TM.
    J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1065-72. PubMed ID: 8407753
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
    Rapport MD, Carlson GA, Kelly KL, Pataki C.
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):333-42. PubMed ID: 8444762
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of methylphenidate and lithium on attention and activity level.
    Carlson GA, Rapport MD, Kelly KL, Pataki CS.
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):262-70. PubMed ID: 1564028
    [Abstract] [Full Text] [Related]

  • 8. Growth deficits in children treated with desipramine: a controlled study.
    Spencer T, Biederman J, Wright V, Danon M.
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder.
    Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA.
    Pediatrics; 1995 Aug; 96(2 Pt 1):320-5. PubMed ID: 7630692
    [Abstract] [Full Text] [Related]

  • 12. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
    Gadow KD, Nolan E, Sprafkin J, Sverd J.
    J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 14. Adverse side effects of methylphenidate among mentally retarded children with ADHD.
    Handen BL, Feldman H, Gosling A, Breaux AM, McAuliffe S.
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):241-5. PubMed ID: 2016228
    [Abstract] [Full Text] [Related]

  • 15. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK, Park S, Wang HR, Lee JS, Kim K, Paik KW, Yum MS, Ko TS.
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of desipramine in children.
    Schroeder JS, Mullin AV, Elliott GR, Steiner H, Nichols M, Gordon A, Paulos M.
    J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):376-9. PubMed ID: 2661525
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemelä A, Trott GE, Lee E, Buitelaar JK.
    Biol Psychiatry; 2008 May 15; 63(10):981-9. PubMed ID: 18206857
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 15; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.